Sagimet Biosciences
Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways. The company has unique expertise in FASN biology and has created a pipeline of proprietary FASN inhibitors.
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does Sagimet Biosciences use?+
We have not yet detected technologies for Sagimet Biosciences.
What industry is Sagimet Biosciences in?+
Sagimet Biosciences operates in the Biopharma industry.
Where is Sagimet Biosciences based?+
Sagimet Biosciences is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026